Search
Showing results for "8"
News & Events
Every Friday: Child Health Research Seminars 2014Associate Professor Roz Walker has been involved in research, evaluation and education with Aboriginal communities building local capacity for 30 years.
News & Events
Trans Tasman action to fast track rheumatic fever vaccinePrime Ministers of Australia and New Zealand have agreed to provide $3M to help fast-track the development of a vaccine against rheumatic fever.
News & Events
Investigational vaccine for WA's meningococcal threatPerth researchers have begun a clinical trial of an investigational Meningococcal B vaccine against the most common form of meningococcal disease in W.A.
News & Events
Fiona Stanley honoured at WA’s most prestigious science awardsProfessor Fiona Stanley, Director of the Telethon Institute for Child Health Research, has been inducted into the Science Hall of Fame.
News & Events
Potential new vaccine for WA's meningococcal threatPerth researchers are trialling a Meningococcal B vaccine that could potentially provide protection
News & Events
Jim McGinty joins child health research BoardFormer WA Health Minister, the Hon Jim McGinty, has been appointed to the Board of Perth's The Kids for Child Health Research.
News & Events
Vaccinating society against long-term labour shortagesCommunity health and education programs may help Australia avert chronic labour and skills shortages in the decades ahead, according to Professor Fiona Stanley.
News & Events
Asthma steroid without side effectsWestern Australia has joined a major international study that could significantly change the treatment of asthma in children.
News & Events
Launch of National Autism GuidelineResearchers from The Kids Research Institute Australia, working with the Autism CRC, have led the development of the National Guideline for the Assessment and Diagnosis of Autism Spectrum Disorder in Australia which was launched today.
Research
EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responsesHigh-grade gliomas including glioblastoma (GBM) and diffuse midline gliomas (DMG) represent the most lethal and aggressive brain cancers where current treatment modalities offer limited efficacy. Chimeric antigen receptor (CAR) T cell therapies have emerged as a promising strategy, boasting tumor-specific targeting and the unique ability to penetrate the blood-brain barrier.